Skip to content
value.today
Biodesix Inc. logo

Biodesix Inc.

🇺🇸 Broomfield, Colorado, USABiotechnologyFounded 2005

Formerly Elston Technologies, Inc.

Total raised
$127 M
14 rounds on record
Latest round
$18 M
Oct 2018
First round on record
Sep 2009
Today
Went public
See the company page

Biodesix Inc. is listed today as Biodesix, Inc.: market value, financials and filings are on its company page.

Funding rounds

14 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Biodesix Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2018$18 MNo. 14$10 to $50 million

Biodesix Inc.: Raise no. 14, Oct 2018

Investors in this round

33 investors had bought by the notice of Oct 23, 2018: 33 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$18 M of $28 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bobbi Coffin · Executive Officer
  • David Brunel · Executive Officer, Director
  • Gary Pestano, Ph.D. · Executive Officer
  • Heinrich Roder, D.Phil. · Executive Officer
  • Jim Purvis · Executive Officer
  • Linda Traylor, Ph.D. · Executive Officer
  • Matt Stauffer · Executive Officer
  • Paul Beresford, Ph.D. · Executive Officer
  • Robin Cowie · Executive Officer
  • Scott Hutton · Executive Officer
  • Jack Schuler · Director
  • John Patience · Director
  • Mark Miller · Director
  • Matthew Strobeck · Director
  • Robert Cawthorn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The amount sold includes $10,511,735.63 through the issuance of stock upon the conversion of outstanding convertible securities.”

Signed by Robin H. Cowie, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 23, 2018. Read the notice at the SEC.

equitySEC
Jun 2018$8 MIssued in a merger or acquisition$2 to $10 million

Biodesix Inc.: Private sale, Jun 2018

Investors in this round

1 investor had bought by the notice of Jul 18, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bobbi Coffin · Executive Officer
  • David Brunel · Executive Officer, Director
  • Gary Pestano, Ph.D. · Executive Officer
  • Heinrich Roder, D.Phil · Executive Officer
  • Jim Purvis · Executive Officer
  • Linda Traylor, Ph.D. · Executive Officer
  • Paul Beresford, Ph.D. · Executive Officer
  • Robin Cowie · Executive Officer
  • Scott Hutton · Executive Officer
  • Jack Schuler · Director
  • John Patience · Director
  • Mark Miller · Director
  • Matthew Strobeck · Director
  • Robert Cawthorn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Stock issued in exchange for assets. Value of stock estimated based on the original issue price of the same class and series of stock in February 2018.”

Signed by Robin H. Cowie, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Jul 18, 2018. Read the notice at the SEC.

equitySEC
Feb 2018$2 MNo. 13Under $2 million

Biodesix Inc.: Raise no. 13, Feb 2018

Investors in this round

1 investor had bought by the notice of Mar 9, 2018: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bobbi Coffin · Executive Officer
  • David Brunel · Executive Officer, Director
  • Gary Pestano, Ph.D. · Executive Officer
  • Heinrich Roder, D.Phil. · Executive Officer
  • Jim Purvis · Executive Officer
  • Linda Traylor, Ph.D. · Executive Officer
  • Paul Beresford, Ph.D. · Executive Officer
  • Robin Cowie · Executive Officer
  • Scott Hutton · Executive Officer
  • Jack Schuler · Director
  • John Patience · Director
  • Mark Miller · Director
  • Matthew Strobeck · Director
  • Robert Cawthorn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Brunel, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 9, 2018. Read the notice at the SEC.

equity, optionsSEC
Apr 2017$13 MNo. 12$10 to $50 million

Biodesix Inc.: Raise no. 12, Apr 2017

Investors in this round

17 investors had bought by the notice of Apr 24, 2017: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$13 M of $25 M offered; $12 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bobbi Coffin · Executive Officer
  • David Brunel · Executive Officer, Director
  • Gary Pestano, Ph.D. · Executive Officer
  • Heinrich Roder, D.Phil. · Executive Officer
  • Jim Purvis · Executive Officer
  • Linda Traylor, Ph.D. · Executive Officer
  • Liz Fliegelman · Executive Officer
  • Paul Beresford, Ph.D. · Executive Officer
  • Robin Cowie · Executive Officer
  • Wendy Blosser · Executive Officer
  • Jack Schuler · Director
  • John Patience · Director
  • Mark Miller · Director
  • Matthew Strobeck · Director
  • Robert Cawthorn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The amount sold includes the conversion of outstanding convertible indebtedness.”

Signed by David Brunel, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 24, 2017. Read the notice at the SEC.

equitySEC
Jul 2016$6 MNo. 11$2 to $10 million

Biodesix Inc.: Raise no. 11, Jul 2016

Investors in this round

15 investors had bought by the notice of Jul 27, 2016: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$6 M of $7 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Brunel · Executive Officer, Director
  • Robin Cowie · Executive Officer
  • Jack Schuler · Director
  • John Patience · Director
  • Mark Miller · Director
  • Matthew Strobeck · Director
  • Robert Cawthorn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Brunel, Chief Executive Officer. Source: SEC Form D, newest notice filed Jul 27, 2016. Read the notice at the SEC.

equitySEC
Jan 2016$18 MNo. 10$10 to $50 million

Biodesix Inc.: Raise no. 10, Jan 2016

Investors in this round

24 investors had bought by the notice of Feb 12, 2016: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$18 M of $22 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Contingent value rights relating to revenue from one of Issuer's products
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Brunel · Executive Officer, Director
  • Frank Ronchetti · Executive Officer
  • Jack Schuler · Director
  • John Patience · Director
  • Mark Miller · Director
  • Matthew Strobeck · Director
  • Robert Cawthorn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Offer and sale of Series F Preferred Stock, conversion of Convertible Promissory Notes and offer and sale of contingent value rights relating to revenue from one of the Issuer's products”

Signed by David Brunel, Chief Executive Officer. Source: SEC Form D, newest notice filed Feb 12, 2016. Read the notice at the SEC.

equitySEC
Jun 2015$10 MNo. 9$10 to $50 million

Biodesix Inc.: Raise no. 9, Jun 2015

Investors in this round

24 investors had bought by the notice of Jun 23, 2015: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$10 M of $15 M offered; $5 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Brunel · Executive Officer, Director
  • Frank Ronchetti · Executive Officer
  • Jack Schuler · Director
  • John Patience · Director
  • Mark Miller · Director
  • Matthew Strobeck · Director
  • Robert Cawthorn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Frank Ronchetti, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 23, 2015. Read the notice at the SEC.

equity, optionsSEC
Dec 2014$11 MNo. 8$10 to $50 million

Biodesix Inc.: Raise no. 8, Dec 2014

Investors in this round

19 investors had bought by the notice of Jan 13, 2015: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$11 M of $18 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Brunel · Executive Officer, Director
  • Frank Ronchetti · Executive Officer
  • Jack Schuler · Director
  • John Patience · Director
  • Mark Miller · Director
  • Matthew Strobeck · Director
  • Robert Cawthorn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Frank Ronchetti, Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 13, 2015. Read the notice at the SEC.

equity, optionsSEC
Nov 2013$14 MNo. 7$10 to $50 million

Biodesix Inc.: Raise no. 7, Nov 2013

Investors in this round

26 investors had bought by the notice of Jan 13, 2014: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$14 M of $16 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Includes conversion of principal and interest under outstanding promissory notes.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Brunel · Executive Officer, Director
  • Frank Ronchetti · Executive Officer
  • Jack Schuler · Director
  • John Patience · Director
  • Mark Miller · Director
  • Matthew Strobeck · Director
  • Robert Cawthorn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Frank Ronchetti, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Jan 13, 2014. Read the notice at the SEC.

equitySEC
Oct 2013$4 MNo. 6$2 to $10 million

Biodesix Inc.: Raise no. 6, Oct 2013

Investors in this round

21 investors had bought by the notice of Oct 22, 2013: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them, other: Promissory notes convertible into equity securities of the Company.
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Brunel · Executive Officer, Director
  • Frank Ronchetti · Executive Officer
  • Jack Schuler · Director
  • John Patience · Director
  • Mark Miller · Director
  • Matthew Strobeck · Director
  • Robert Cawthorn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Frank Ronchetti, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 22, 2013. Read the notice at the SEC.

optionsSEC
Mar 2013$7 MNo. 5$2 to $10 million

Biodesix Inc.: Raise no. 5, Mar 2013

Investors in this round

23 investors had bought by the notice of Apr 11, 2013: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$7 M of $15 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Brunel · Executive Officer, Director
  • Frank Ronchetti · Executive Officer
  • Jack Schuler · Director
  • John Patience · Director
  • Mark Miller · Director
  • Matthew Strobeck · Director
  • Robert Cawthorn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Frank Ronchetti, Chief Financial Officer. Source: SEC Form D, newest notice filed Apr 11, 2013. Read the notice at the SEC.

equity, optionsSEC
Aug 2012$6 MNo. 4$2 to $10 million

Biodesix Inc.: Raise no. 4, Aug 2012

Investors in this round

11 investors had bought by the notice of Sep 4, 2012: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$6 M of $13 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Brunel · Executive Officer, Director
  • Frank Ronchetti · Executive Officer
  • Jack Schuler · Director
  • John Patience · Director
  • Mark Miller · Director
  • Matthew Strobeck · Director
  • Robert Cawthorn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Frank Ronchetti, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 4, 2012. Read the notice at the SEC.

equitySEC
Jun 2011$10 MNo. 3$10 to $50 million

Biodesix Inc.: Raise no. 3, Jun 2011

Investors in this round

13 investors had bought by the notice of Jul 5, 2011: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$10 M of $20 M offered; $10 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Brunel · Executive Officer, Director
  • Frank Ronchetti · Executive Officer
  • Heinrich Roder · Executive Officer, Director
  • Jack Schuler · Director
  • John Patience · Director
  • Robert Cawthorn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Frank Ronchetti, Chief Financial Officer. Source: SEC Form D, newest notice filed Jul 5, 2011. Read the notice at the SEC.

equitySEC
Oct 2010$4 MNo. 2$2 to $10 million

Biodesix Inc.: Raise no. 2, Oct 2010

Investors in this round

16 investors had bought by the notice of Oct 28, 2010: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$4 M of $7 M offered; $4 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Brunel · Executive Officer, Director
  • Frank Ronchetti · Executive Officer
  • Heinrich Roder · Executive Officer, Director
  • Jack Schuler · Director
  • John Patience · Director
  • Robert Cawthorn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Frank Ronchetti, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 28, 2010. Read the notice at the SEC.

equitySEC
Sep 2009$5 MNo. 1$2 to $10 million

Biodesix Inc.: Raise no. 1, Sep 2009

Investors in this round

12 investors had bought by the notice of Oct 23, 2009: 12 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Biodesix Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$5 M of $10 M offered; $5 M still to sell
Smallest investment taken
$285
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Brunel · Executive Officer, Director
  • Frank Ronchetti · Executive Officer
  • Heinrich Roder · Executive Officer, Director
  • Jack Schuler · Director
  • John Patience · Director
  • Robert Cawthorn · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Frank Ronchetti, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Oct 23, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company Biodesix, Inc., its revenue in fiscal 2025 came from these product and service lines: Diagnostic Tests $79.20 million (89%), Development Services $9.30 million (11%).

    Annual report (SEC XBRL) · Dec 2025

  • Biodesix Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2018).

    SEC Form D · Oct 2018

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Oct 2018

Products and services#

No products or services of Biodesix Inc. are on record.

Investors#

1 named in official filings. Open an investor to see everything it has backed.

Investors in Biodesix Inc.
InvestorKindAmountRoundRoleSource
Matthew StrobeckPersonnot statednot statedHeld Series C, D, E, F, G and H preferred stock, director (Form 3, 2020)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 14 rounds above had up to 33 investors.

Largest shareholders today

Institutions holding Biodesix, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Biodesix Inc.
NameRoleNamed in
Bobbi CoffinExecutive officerOct 2018
David BrunelExecutive officerOct 2018
Gary Pestano, Ph.D.Executive officerOct 2018
Heinrich Roder, D.Phil.Executive officerOct 2018
Jim PurvisExecutive officerOct 2018
Linda Traylor, Ph.D.Executive officerOct 2018
Matt StaufferExecutive officerOct 2018
Paul Beresford, Ph.D.Executive officerOct 2018
Robin CowieExecutive officerOct 2018
Scott HuttonExecutive officerOct 2018
Heinrich Roder, D.PhilExecutive officerJul 2018
Liz FliegelmanExecutive officerApr 2017
Wendy BlosserExecutive officerApr 2017
Frank RonchettiExecutive officerFeb 2016
Heinrich RoderExecutive officerJul 2011
David BrunelDirectorOct 2018
Jack SchulerDirectorOct 2018
John PatienceDirectorOct 2018
Mark MillerDirectorOct 2018
Matthew StrobeckDirectorOct 2018
Robert CawthornDirectorOct 2018
Heinrich RoderDirectorJul 2011

Went public since 2020. Its SEC number is that of a company listed on a stock exchange.